🇺🇸 FDA
Pipeline program

PN-232

PN-232-01

Phase 1 small_molecule completed

Quick answer

PN-232 for Healthy Subjects is a Phase 1 program (small_molecule) at Protagonist Therapeutics, Inc with 1 ClinicalTrials.gov record(s).

Program details

Company
Protagonist Therapeutics, Inc
Indication
Healthy Subjects
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials